CD36 and prostate carcinoma: Expression of fatty acid transporter proteins is regulated by fatty acid availability, and blocking CD36-dependent uptake enhanced the sensitivity of prostate cancer cells to inhibition of FASN and a combination of C75 with radiation, indicating that it should be considered as an addition to the therapeutic options for tumors that depend on high levels of lipids for growth.